Deep Track Capital, LP Sage Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
A detailed history of Deep Track Capital, LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 2,038,845 shares of SAGE stock, worth $14.6 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
2,038,845Holding current value
$14.6 Million% of portfolio
0.57%Shares
4 transactions
Others Institutions Holding SAGE
# of Institutions
208Shares Held
42.6MCall Options Held
312KPut Options Held
294K-
Black Rock Inc. New York, NY5.22MShares$37.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$36.4 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$32.1 Million4.6% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$12.6 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.62MShares$11.6 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $426M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...